08 January 2025
: Case report 
Radiological and Pathological Analysis of Pembrolizumab-Associated Lung Lesions: Diagnostic Challenges and Management
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Adverse events of drug therapy, Clinical situation which can not be reproduced for ethical reasons
Tomohito Okano BDEF 1, Hajime Fujimoto ABC 1, Toshiyuki Ito BDE 1, Atsushi Tomaru BDE 1, Haruko Saiki BDE 1, Tatsuki Tsuruga ABE 1, Taro Yasuma BCD 2,3, Corina N. D'Alessandro-Gabazza CDE 2,3, Esteban C. Gabazza
DF 1,2,3*, Tetsu Kobayashi ABDE 1,3
DOI: 10.12659/AJCR.945022
Am J Case Rep 2025; 26:e945022
Figure 1. Plain radiograph findings. Before the initiation of the 31st treatment cycle with pembrolizumab, anterior (A) and lateral (B) chest radiographs were performed. These images revealed bilaterally distributed infiltrates and nodular opacities, interspersed with areas of ground-glass opacity throughout the lung fields.